In line with the role of the different proteins in the metabolic remodeling of cancer cells and the evidence from the associations with the clinicopathological data, plasma membrane expression of MCT1 or GLUT1 was identified as a poor prognostic factor and plasma membrane expression of MCT2 was identified as a good prognostic factor for overall survival in univariate analysis. The gene discussed is SLC2A1; the disease is cancer.